10 analysts have expressed a variety of opinions on Quest Diagnostics (NYSE:DGX) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick ...

In the field of pathology, the integration of artificial intelligence (AI) and genomics is paving the way for precision diagnostics that were once thought ...

Historically, diagnostic testing has taken a one-size-fits-all approach: Doctors order tests, health professionals collect the sample, laboratorians conduct the assays, and results are sent back to ...

DUBLIN--(BUSINESS WIRE)--The "Companion Diagnostic Markets - the Future of Diagnostics by Application, Technology and Funding With Executive and Consultant Guides 2023-2027" report has been added to ...

In this episode, Laura Dyrda interviews Dr. Paul Kruszka, Clinical Geneticist at Children’s National Hospital in Washington, D.C. Dr. Kruszka shares insights into the latest advancements in genomic ...

Quest Diagnostics (NYSE:DGX) is preparing to release its quarterly earnings on Tuesday, 2025-04-22. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

TAMPA (BLOOM) – Triple-Board Certified Physician, Dr. Lisa Koche, joined Gayle Guyardo, the host of the global health and wellness show, Bloom, sharing some of the trends shaping the future of ...

Hologic’s HOLX Diagnostics unit, the largest by revenues, has been the most impacted by geopolitical headwinds this year. Cuts in USAID funding have affected its HIV testing business in Africa, while ...

Companion diagnostics in fields like oncology are well-known, but it’s their potential impact on psychiatry that is gaining attention and has the potential to shape the future of the industry.